接受长期联合抗逆转录病毒治疗的 HIV 感染儿童的骨密度增加。
Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy.
机构信息
Department of Paediatric Immunology, Haematology, and Infectious Diseases, Emma Children Hospital, Amsterdam, The Netherlands.
出版信息
Clin Infect Dis. 2013 Feb;56(4):583-6. doi: 10.1093/cid/cis917. Epub 2012 Oct 24.
PMID:23097583
Abstract
The long-term treatment of human immunodeficiency virus (HIV)-infected children with combination antiretroviral therapy (cART) requires assessment of potential adverse effects, such as osteoporosis. Longitudinal data on bone mineral density (BMD) in HIV-infected children showed that cumulative treatment with cART had a positive impact on BMD over time.
摘要
对接受联合抗逆转录病毒疗法（cART）治疗的人类免疫缺陷病毒（HIV）感染儿童进行长期治疗需要评估潜在的不良反应，例如骨质疏松症。HIV 感染儿童的骨矿物质密度（BMD）纵向数据显示，随着时间的推移，cART 的累积治疗对 BMD 有积极影响。
Zotero 插件